Genuone Sciences

Provider of drug formulation and supply chain services to biopharma sector

placeSeoul, Seoul, South Korea calendar_todayFounded 2020 groups677 employees language genuonesciences.com

Innovation

21 patent families (2 granted) — focus: Human necessities; filing pace steady. Cited 110 times.

YearFilings
20214
20226
20232
20242
20257

Investor mix

1 investor on record; 1 has since exited.

Investor typeCountShare
Private equity1100%
Coming soon